Hamilton Thorne Ltd.
HTL
Rank in Stocks
#16941
Hamilton Thorne Ltd. is a leading enterprise focused on the development,... Hamilton Thorne Ltd. is a leading enterprise focused on the development, manufacturing, and global distribution of specialized instrumentation, laboratory equipment, consumables, software, and a range of services. The company's offerings are primarily directed towards the fields of assisted reproductive technologies (ART), scientific research, and cell biology. Their product line includes sophisticated laser and imaging systems designed for biological studies, custom-built workstations, incubators, and essential equipment for IVF laboratories. They also produce critical medical devices for reproductive medicine, such as ovum pickup needles and catheters, and provide comprehensive in-vitro diagnostic (IVD) systems, from initial research and design to sales, installation, and ongoing servicing. Environmental control solutions like the Cell-Tek Microscope Chamber, which meticulously manages temperature, airflow, and humidity, are also part of their extensive catalog, alongside laminar flow workstations. Furthermore, Hamilton Thorne pioneers software innovations, including AI-powered CASA (Computer-Assisted Sperm Analysis) for image analysis. The company's service array covers thorough laboratory testing, notably endotoxin analysis and specialized sperm assays (like the Sperm Motility Index and Sperm Penetration), as well as the provision of fresh and cryopreserved mouse embryos, coupled with technician training and proficiency testing programs. Marketed under respected brand names such as Hamilton Thorne, Gynemed, Planer, Tek-Event, IVFtech, MICROPTIC, Gynétics, and Embryotech, their products and services reach a diverse global customer base—including fertility clinics, hospitals, pharmaceutical and biotechnology companies, academic institutions, and various commercial research entities—via a direct sales presence in countries like the United States, Germany, France, Australia, Denmark, Belgium, Spain, and the United Kingdom, complemented by an extensive distributor network covering around 100 nations. Hamilton Thorne Ltd. maintains its headquarters in Beverly, Massachusetts.
Share Price
$1.64
Last synced: 2024-12-02
Market Cap
$253.46M
Change (1 day)
2.87%
Change (1 year)
3.40%
Country
US
Trade Hamilton Thorne Ltd. (HTL)
Category
Healthcare
P/E ratio for Hamilton Thorne Ltd. (HTL)
P/E ratio as of October 2026 TTM: -387.83
According to Hamilton Thorne Ltd. latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -387.83. At the end of 2022 the company had a P/E ratio of 91.33.
P/E ratio history for Hamilton Thorne Ltd. from 2008 to 2026
P/E ratio at the end of each year
| Year | P/E Ratio | Change |
|---|---|---|
| 2026 (TTM) | -387.83 | 59.24% |
| 2023 | -243.55 | -366.69% |
| 2022 | 91.33 | -4.30% |
| 2021 | 95.43 | -39.39% |
| 2020 | 157.45 | 26.56% |
| 2019 | 124.41 | 371.95% |
| 2018 | 26.36 | 161.23% |
| 2017 | 10.09 | -72.34% |
| 2016 | 36.48 | 279.55% |
| 2015 | 9.61 | -56.10% |
| 2014 | 21.90 | 14.40% |
| 2013 | 19.14 | -996.31% |
| 2012 | -2.14 | 72.31% |
| 2011 | -1.24 | 28.28% |
| 2010 | -0.97 | 40.85% |
| 2009 | -0.69 | 565.28% |
| 2008 | -0.10 | 0.00% |
P/E ratio for similar companies or competitors
| Company | P/E Ratio | P/E Ratio Difference | Country |
|---|---|---|---|
| 47.48 | -112.24% |
US
|
|
| 27.43 | -107.07% |
FR
|
|
| - | - |
JP
|
|
| 56.89 | -114.67% |
US
|
|
| - | - |
CH
|
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.